How we work with industry
|The AIBN has a strong commercial focus.|
The AIBN’s Innovation and Commercial Development (I&CD) team focuses on the intellectual property (IP) management and commercialisation of the Institute’s research and development activities, as well as fostering industry-led collaborations and contract research.
The AIBN has a strong commercial focus. To support and rapidly build the Institute’s commercialisation activity, AIBN has a strategic relationship with UniQuest Pty Limited providing access to commercialisation expertise, processes and resources. UniQuest is recognised as an Australian leader in research commercialisation and is the main commercialisation company of The University of Queensland.
The commercial objective of the Institute is to produce innovations assisting in the growth of industries; the development of new products, processes and technologies; and play a major role in developing the Australian nanotechnology and biotechnology industries. This objective will be met through a dual commercialisation strategy.
The ‘inside-out’ strategy provides for the development of AIBN’s IP through market-led R&D, funded from public and private sources as appropriate and commercialised via a license agreement or forming a start-up company to further develop the technology into a product.
In contrast the ‘outside-in’ strategy aims to capitalise on AIBN’s capabilities, infrastructure and intellectual capital by working closely for or with industry.
I&CD engages with key figures in the bioengineering and nanotechnology industries, to determine their various needs, which often results in commercial discussions leading to consultancy and collaborative research arrangements, contract research and license agreements.
Translating cutting-edge research into commercial outcomes and societal benefits is core to the AIBN mission.Read more ›